Sunday, 23 June 2024

IVI announces 'vaccines partnership' with London School of Hygiene & Tropical Medicine

04 October 2022 | News

To accelerate vaccines for global health through joint training and research and development

image credit- IVI

image credit- IVI

South Korea-based International Vaccine Institute (IVI) and the London School of Hygiene & Tropical Medicine (LSHTM) have signed a Memorandum of Understanding (MoU) to establish a collaborative partnership.

Joint activities will include developing materials to train early-career vaccinologists as well as collaborating across the entire spectrum of vaccine development.

Dr Jerome Kim, Director General of IVI, said: “LSHTM alumni represent a number of IVI epidemiologists, clinicians, and biostatisticians, and we look forward to combining our multidisciplinary expertise to double our impact in improving global health through vaccination and capacity-building.”

Professor Dame Anne Mills, Deputy Director and Provost at LSHTM, said: “We look forward to strengthening our collaborations across every stage of vaccine evaluation. This includes basic science, preclinical studies and clinical trials, effectiveness and implementation studies, epidemiology, modelling, and economic evaluation to generate evidence for policy and facilitate introduction, uptake, and sustainable impact on vaccine equity.”

IVI and LSHTM share a commitment to facilitating the transfer of knowledge, know-how and technology to build capacity and collaborative networks, particularly in low-resource settings. LSHTM faculty regularly join an esteemed group of lecturers for the annual International Vaccinology Course, IVI’s flagship training programme.


Image caption- L-R- Professor Dame Anne Mills, Deputy Director and Provost at LSHTM, and Dr Jerome Kim, Director General of IVI

Sign up for the editor pick and get articles like this delivered right to your inbox.

Editors Pick
+Country Code-Phone Number(xxx-xxxxxxx)


× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account